Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Onco-Innovations Ltd. ( (TSE:ONCO) ) has issued an announcement.
Onco-Innovations Limited has appointed Dr. John Mackey to its Scientific and Clinical Advisory Board, leveraging his extensive experience in oncology and clinical trials to advance its PNKP inhibitor program. Dr. Mackey’s expertise in translational research and clinical execution is expected to enhance the company’s development path for its oncology therapeutics, potentially strengthening its industry position and benefiting stakeholders.
More about Onco-Innovations Ltd.
Onco-Innovations Limited is a Canadian-based company focused on cancer research and treatment, specializing in oncology. The company aims to prevent and treat cancer through pioneering research and innovative solutions, holding an exclusive worldwide license for patented technology targeting solid tumors.
Average Trading Volume: 85,690
Technical Sentiment Signal: Hold
For an in-depth examination of ONCO stock, go to TipRanks’ Overview page.